The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global HIV and AIDS Clinical Trials Market Research Report 2025
Synopsis
HIV and AIDS clinical trials help researchers find better ways to prevent, detect, or treat HIV and AIDS. Examples of HIV and AIDS clinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV and AIDS.
The global HIV and AIDS Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HIV and AIDS Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HIV and AIDS Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV and AIDS Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV and AIDS Clinical Trials.
Report Scope
The HIV and AIDS Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV and AIDS Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV and AIDS Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV and AIDS Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
HIV and AIDS clinical trials help researchers find better ways to prevent, detect, or treat HIV and AIDS. Examples of HIV and AIDS clinical trials underway include studies of new HIV medicines, studies of vaccines to prevent or treat HIV, and studies of medicines to treat infections related to HIV and AIDS.
The global HIV and AIDS Clinical Trials market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for HIV and AIDS Clinical Trials is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for HIV and AIDS Clinical Trials in Pharmaceutical & Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of HIV and AIDS Clinical Trials include PPD Inc., IQVIA Inc., Parexel International Corporation, ICON plc, Syneos Health, WuXi AppTec, Janssen Global Services, LLC, Gilead Sciences, Inc. and Bionor Holding AS, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for HIV and AIDS Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding HIV and AIDS Clinical Trials.
Report Scope
The HIV and AIDS Clinical Trials market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global HIV and AIDS Clinical Trials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the HIV and AIDS Clinical Trials companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
PPD Inc.
IQVIA Inc.
Parexel International Corporation
ICON plc
Syneos Health
WuXi AppTec
Janssen Global Services, LLC
Gilead Sciences, Inc.
Bionor Holding AS
Charles River Laboratories
GSK plc.
SGS SA
Segment by Type
Phase I
Phase II
Phase III
Phase IV
Segment by Application
Pharmaceutical & Biopharmaceutical Companies
Non Profit Organizations
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of HIV and AIDS Clinical Trials companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Phase I
1.2.3 Phase II
1.2.4 Phase III
1.2.5 Phase IV
1.3 Market by Application
1.3.1 Global HIV and AIDS Clinical Trials Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Non Profit Organizations
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global HIV and AIDS Clinical Trials Market Perspective (2019-2030)
2.2 HIV and AIDS Clinical Trials Growth Trends by Region
2.2.1 Global HIV and AIDS Clinical Trials Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 HIV and AIDS Clinical Trials Historic Market Size by Region (2019-2024)
2.2.3 HIV and AIDS Clinical Trials Forecasted Market Size by Region (2025-2030)
2.3 HIV and AIDS Clinical Trials Market Dynamics
2.3.1 HIV and AIDS Clinical Trials Industry Trends
2.3.2 HIV and AIDS Clinical Trials Market Drivers
2.3.3 HIV and AIDS Clinical Trials Market Challenges
2.3.4 HIV and AIDS Clinical Trials Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top HIV and AIDS Clinical Trials Players by Revenue
3.1.1 Global Top HIV and AIDS Clinical Trials Players by Revenue (2019-2024)
3.1.2 Global HIV and AIDS Clinical Trials Revenue Market Share by Players (2019-2024)
3.2 Global HIV and AIDS Clinical Trials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by HIV and AIDS Clinical Trials Revenue
3.4 Global HIV and AIDS Clinical Trials Market Concentration Ratio
3.4.1 Global HIV and AIDS Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by HIV and AIDS Clinical Trials Revenue in 2023
3.5 HIV and AIDS Clinical Trials Key Players Head office and Area Served
3.6 Key Players HIV and AIDS Clinical Trials Product Solution and Service
3.7 Date of Enter into HIV and AIDS Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans
4 HIV and AIDS Clinical Trials Breakdown Data by Type
4.1 Global HIV and AIDS Clinical Trials Historic Market Size by Type (2019-2024)
4.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2025-2030)
5 HIV and AIDS Clinical Trials Breakdown Data by Application
5.1 Global HIV and AIDS Clinical Trials Historic Market Size by Application (2019-2024)
5.2 Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America HIV and AIDS Clinical Trials Market Size (2019-2030)
6.2 North America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America HIV and AIDS Clinical Trials Market Size by Country (2019-2024)
6.4 North America HIV and AIDS Clinical Trials Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe HIV and AIDS Clinical Trials Market Size (2019-2030)
7.2 Europe HIV and AIDS Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe HIV and AIDS Clinical Trials Market Size by Country (2019-2024)
7.4 Europe HIV and AIDS Clinical Trials Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific HIV and AIDS Clinical Trials Market Size (2019-2030)
8.2 Asia-Pacific HIV and AIDS Clinical Trials Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2019-2024)
8.4 Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America HIV and AIDS Clinical Trials Market Size (2019-2030)
9.2 Latin America HIV and AIDS Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America HIV and AIDS Clinical Trials Market Size by Country (2019-2024)
9.4 Latin America HIV and AIDS Clinical Trials Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa HIV and AIDS Clinical Trials Market Size (2019-2030)
10.2 Middle East & Africa HIV and AIDS Clinical Trials Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2019-2024)
10.4 Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PPD Inc.
11.1.1 PPD Inc. Company Detail
11.1.2 PPD Inc. Business Overview
11.1.3 PPD Inc. HIV and AIDS Clinical Trials Introduction
11.1.4 PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.1.5 PPD Inc. Recent Development
11.2 IQVIA Inc.
11.2.1 IQVIA Inc. Company Detail
11.2.2 IQVIA Inc. Business Overview
11.2.3 IQVIA Inc. HIV and AIDS Clinical Trials Introduction
11.2.4 IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.2.5 IQVIA Inc. Recent Development
11.3 Parexel International Corporation
11.3.1 Parexel International Corporation Company Detail
11.3.2 Parexel International Corporation Business Overview
11.3.3 Parexel International Corporation HIV and AIDS Clinical Trials Introduction
11.3.4 Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.3.5 Parexel International Corporation Recent Development
11.4 ICON plc
11.4.1 ICON plc Company Detail
11.4.2 ICON plc Business Overview
11.4.3 ICON plc HIV and AIDS Clinical Trials Introduction
11.4.4 ICON plc Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.4.5 ICON plc Recent Development
11.5 Syneos Health
11.5.1 Syneos Health Company Detail
11.5.2 Syneos Health Business Overview
11.5.3 Syneos Health HIV and AIDS Clinical Trials Introduction
11.5.4 Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.5.5 Syneos Health Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Detail
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec HIV and AIDS Clinical Trials Introduction
11.6.4 WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.6.5 WuXi AppTec Recent Development
11.7 Janssen Global Services, LLC
11.7.1 Janssen Global Services, LLC Company Detail
11.7.2 Janssen Global Services, LLC Business Overview
11.7.3 Janssen Global Services, LLC HIV and AIDS Clinical Trials Introduction
11.7.4 Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.7.5 Janssen Global Services, LLC Recent Development
11.8 Gilead Sciences, Inc.
11.8.1 Gilead Sciences, Inc. Company Detail
11.8.2 Gilead Sciences, Inc. Business Overview
11.8.3 Gilead Sciences, Inc. HIV and AIDS Clinical Trials Introduction
11.8.4 Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.8.5 Gilead Sciences, Inc. Recent Development
11.9 Bionor Holding AS
11.9.1 Bionor Holding AS Company Detail
11.9.2 Bionor Holding AS Business Overview
11.9.3 Bionor Holding AS HIV and AIDS Clinical Trials Introduction
11.9.4 Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.9.5 Bionor Holding AS Recent Development
11.10 Charles River Laboratories
11.10.1 Charles River Laboratories Company Detail
11.10.2 Charles River Laboratories Business Overview
11.10.3 Charles River Laboratories HIV and AIDS Clinical Trials Introduction
11.10.4 Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.10.5 Charles River Laboratories Recent Development
11.11 GSK plc.
11.11.1 GSK plc. Company Detail
11.11.2 GSK plc. Business Overview
11.11.3 GSK plc. HIV and AIDS Clinical Trials Introduction
11.11.4 GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.11.5 GSK plc. Recent Development
11.12 SGS SA
11.12.1 SGS SA Company Detail
11.12.2 SGS SA Business Overview
11.12.3 SGS SA HIV and AIDS Clinical Trials Introduction
11.12.4 SGS SA Revenue in HIV and AIDS Clinical Trials Business (2019-2024)
11.12.5 SGS SA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global HIV and AIDS Clinical Trials Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Phase I
Table 3. Key Players of Phase II
Table 4. Key Players of Phase III
Table 5. Key Players of Phase IV
Table 6. Global HIV and AIDS Clinical Trials Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global HIV and AIDS Clinical Trials Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global HIV and AIDS Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global HIV and AIDS Clinical Trials Market Share by Region (2019-2024)
Table 10. Global HIV and AIDS Clinical Trials Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global HIV and AIDS Clinical Trials Market Share by Region (2025-2030)
Table 12. HIV and AIDS Clinical Trials Market Trends
Table 13. HIV and AIDS Clinical Trials Market Drivers
Table 14. HIV and AIDS Clinical Trials Market Challenges
Table 15. HIV and AIDS Clinical Trials Market Restraints
Table 16. Global HIV and AIDS Clinical Trials Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global HIV and AIDS Clinical Trials Market Share by Players (2019-2024)
Table 18. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2023)
Table 19. Ranking of Global Top HIV and AIDS Clinical Trials Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by HIV and AIDS Clinical Trials Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players HIV and AIDS Clinical Trials Product Solution and Service
Table 23. Date of Enter into HIV and AIDS Clinical Trials Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global HIV and AIDS Clinical Trials Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2019-2024)
Table 27. Global HIV and AIDS Clinical Trials Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global HIV and AIDS Clinical Trials Revenue Market Share by Type (2025-2030)
Table 29. Global HIV and AIDS Clinical Trials Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2019-2024)
Table 31. Global HIV and AIDS Clinical Trials Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global HIV and AIDS Clinical Trials Revenue Market Share by Application (2025-2030)
Table 33. North America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America HIV and AIDS Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America HIV and AIDS Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe HIV and AIDS Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe HIV and AIDS Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific HIV and AIDS Clinical Trials Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific HIV and AIDS Clinical Trials Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America HIV and AIDS Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America HIV and AIDS Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa HIV and AIDS Clinical Trials Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa HIV and AIDS Clinical Trials Market Size by Country (2025-2030) & (US$ Million)
Table 48. PPD Inc. Company Detail
Table 49. PPD Inc. Business Overview
Table 50. PPD Inc. HIV and AIDS Clinical Trials Product
Table 51. PPD Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 52. PPD Inc. Recent Development
Table 53. IQVIA Inc. Company Detail
Table 54. IQVIA Inc. Business Overview
Table 55. IQVIA Inc. HIV and AIDS Clinical Trials Product
Table 56. IQVIA Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 57. IQVIA Inc. Recent Development
Table 58. Parexel International Corporation Company Detail
Table 59. Parexel International Corporation Business Overview
Table 60. Parexel International Corporation HIV and AIDS Clinical Trials Product
Table 61. Parexel International Corporation Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 62. Parexel International Corporation Recent Development
Table 63. ICON plc Company Detail
Table 64. ICON plc Business Overview
Table 65. ICON plc HIV and AIDS Clinical Trials Product
Table 66. ICON plc Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 67. ICON plc Recent Development
Table 68. Syneos Health Company Detail
Table 69. Syneos Health Business Overview
Table 70. Syneos Health HIV and AIDS Clinical Trials Product
Table 71. Syneos Health Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 72. Syneos Health Recent Development
Table 73. WuXi AppTec Company Detail
Table 74. WuXi AppTec Business Overview
Table 75. WuXi AppTec HIV and AIDS Clinical Trials Product
Table 76. WuXi AppTec Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 77. WuXi AppTec Recent Development
Table 78. Janssen Global Services, LLC Company Detail
Table 79. Janssen Global Services, LLC Business Overview
Table 80. Janssen Global Services, LLC HIV and AIDS Clinical Trials Product
Table 81. Janssen Global Services, LLC Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 82. Janssen Global Services, LLC Recent Development
Table 83. Gilead Sciences, Inc. Company Detail
Table 84. Gilead Sciences, Inc. Business Overview
Table 85. Gilead Sciences, Inc. HIV and AIDS Clinical Trials Product
Table 86. Gilead Sciences, Inc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 87. Gilead Sciences, Inc. Recent Development
Table 88. Bionor Holding AS Company Detail
Table 89. Bionor Holding AS Business Overview
Table 90. Bionor Holding AS HIV and AIDS Clinical Trials Product
Table 91. Bionor Holding AS Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 92. Bionor Holding AS Recent Development
Table 93. Charles River Laboratories Company Detail
Table 94. Charles River Laboratories Business Overview
Table 95. Charles River Laboratories HIV and AIDS Clinical Trials Product
Table 96. Charles River Laboratories Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 97. Charles River Laboratories Recent Development
Table 98. GSK plc. Company Detail
Table 99. GSK plc. Business Overview
Table 100. GSK plc. HIV and AIDS Clinical Trials Product
Table 101. GSK plc. Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 102. GSK plc. Recent Development
Table 103. SGS SA Company Detail
Table 104. SGS SA Business Overview
Table 105. SGS SA HIV and AIDS Clinical Trials Product
Table 106. SGS SA Revenue in HIV and AIDS Clinical Trials Business (2019-2024) & (US$ Million)
Table 107. SGS SA Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV and AIDS Clinical Trials Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global HIV and AIDS Clinical Trials Market Share by Type: 2023 VS 2030
Figure 3. Phase I Features
Figure 4. Phase II Features
Figure 5. Phase III Features
Figure 6. Phase IV Features
Figure 7. Global HIV and AIDS Clinical Trials Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global HIV and AIDS Clinical Trials Market Share by Application: 2023 VS 2030
Figure 9. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 10. Non Profit Organizations Case Studies
Figure 11. Others Case Studies
Figure 12. HIV and AIDS Clinical Trials Report Years Considered
Figure 13. Global HIV and AIDS Clinical Trials Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global HIV and AIDS Clinical Trials Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global HIV and AIDS Clinical Trials Market Share by Region: 2023 VS 2030
Figure 16. Global HIV and AIDS Clinical Trials Market Share by Players in 2023
Figure 17. Global Top HIV and AIDS Clinical Trials Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HIV and AIDS Clinical Trials as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by HIV and AIDS Clinical Trials Revenue in 2023
Figure 19. North America HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America HIV and AIDS Clinical Trials Market Share by Country (2019-2030)
Figure 21. United States HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe HIV and AIDS Clinical Trials Market Share by Country (2019-2030)
Figure 25. Germany HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific HIV and AIDS Clinical Trials Market Share by Region (2019-2030)
Figure 33. China HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America HIV and AIDS Clinical Trials Market Share by Country (2019-2030)
Figure 41. Mexico HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa HIV and AIDS Clinical Trials Market Share by Country (2019-2030)
Figure 45. Turkey HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia HIV and AIDS Clinical Trials Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. PPD Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 48. IQVIA Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 49. Parexel International Corporation Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 50. ICON plc Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 51. Syneos Health Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 52. WuXi AppTec Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 53. Janssen Global Services, LLC Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 54. Gilead Sciences, Inc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 55. Bionor Holding AS Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 56. Charles River Laboratories Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 57. GSK plc. Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 58. SGS SA Revenue Growth Rate in HIV and AIDS Clinical Trials Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
